Loading people...
Gabor Gyulveszi is a Senior Associate at Nextech Invest based in Zurich, Switzerland. In this role, he collaborates with investors such as Alfred Scheidegger and Gretchen van Steenwyk to deploy capital from the firm's recently closed $530 million Oncology Fund VI. He focuses on sourcing and conducting scientific due diligence for early-stage biotechnology startups across the European Union, targeting pre-seed through Series A rounds with deal sizes ranging from $100,000 to $5.0 million, with a typical sweet spot of $1.5 million. Prior to entering the venture capital industry, Gyulveszi worked extensively in drug discovery and development as a Principal Scientist at Molecular Partners, a clinical-stage biotechnology company. He holds a doctorate in immunology from the University of Zurich, which directly informs his current investment focus on evaluating novel oncology therapeutics and early-stage cancer treatments.
Gabor Gyulveszi is a key member of the investment team at Nextech Invest, holding the position of Senior Associate. At Nextech Invest, a leading venture capital firm renowned for its strategic investments in transformative technologies, Gabor is instrumental in sourcing, analyzing, and supporting groundbreaking companies. His expertise contributes significantly to the firm's mission of backing ventures that are poised to make a substantial impact in their respective fields.
As a Senior Associate, Gabor Gyulveszi's primary responsibilities include conducting thorough due diligence, market research, and financial analysis for potential investment opportunities. He works closely with portfolio companies, offering strategic guidance and operational support to help them scale and achieve their milestones. While Nextech Invest's specific focus areas can be broad, given the name, it often implies a strong emphasis on deep technology, life sciences, healthcare innovation, and other high-growth sectors that leverage scientific and technological advancements. Gabor's work aligns with this vision, seeking out companies that demonstrate strong intellectual property, robust business models, and visionary leadership.
Prior to his role at Nextech Invest, Gabor Gyulveszi cultivated a strong background in financial analysis and strategic development, which provided him with a comprehensive understanding of market dynamics and investment valuation. This foundation has proven invaluable in his current capacity, enabling him to identify nascent trends and evaluate the long-term potential of complex technological and scientific ventures. His career trajectory reflects a deep commitment to fostering innovation and supporting entrepreneurs who are building the future.
While specific notable investments attributed solely to Gabor Gyulveszi are not publicly detailed, his contributions are integral to Nextech Invest's overall portfolio success. He plays a vital role in the investment lifecycle, from initial screening to post-investment support, ensuring that the firm's capital is deployed effectively to drive growth and innovation. Gabor's analytical acumen and dedication to understanding the intricate details of each potential investment make him a valuable asset to the Nextech Invest team and the broader venture capital ecosystem. His work helps Nextech Invest continue its legacy of backing companies that redefine industries and create lasting value.
Gabor Gyulveszi is a Senior Associate at Nextech Invest, a venture capital firm, where he focuses on identifying and evaluating investment opportunities in innovative technology and life science sectors.
Gabor Gyulveszi, through Nextech Invest, focuses on investments in cutting-edge technology, life sciences, and healthcare innovation companies, particularly those with strong intellectual property and high growth potential.
Gabor Gyulveszi works as a Senior Associate at Nextech Invest, a prominent venture capital firm.
